Inventor · disambiguated record
Scott Holden
Also filed as: HOLDEN SCOTT · HOLDEN SCOTT NAYLOR
0 granted patents·6 pending applications·0 citations·filing 2011–2025
Top patents by PatentIndex Score
6 records- 0181US2023201210A1Combinations of anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2023·Application pending·0 cites
- 0274US2025161315A1Combinations of anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2025·Application pending·0 cites
- 0365US2019374547A1Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2019·Application pending·0 cites
- 0458US2017136026A1Combinations of anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of useGENENTECH INC·Filed 2017·Application pending·0 cites
- 0541US2013096116A1Treatment of pharmacological-induced hypochlorhydriaGENENTECH INC·Filed 2012·Application pending·0 cites
- 0624US2014044709A1Treatment of her2-positive cancer with paclitaxel and trastuzumab-mcc-dm1KLENCKE BARBARA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Scott Holden files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →